ReviewCurrent cardiology reports2025
Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Role of Left Atrial Reservoir Strain for Risk Stratification in Aortic Stenosis: A Systematic Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purpose of reviewTo summarize the recent literature examining the degree of overlap among atrial fibrillation (AF), heart failure (HF), and left atrial (LA) dysfunction, the prognostic relevance of finding a second condition in one of the other disease states, and the treatment effects for one condition on the secondary entities. RECENT
findingsIf one condition (AF, HF, or LA dysfunction) is present, there are very high prevalences of a second condition demonstrated across several cohorts. Additionally, the presence of a second condition consistently has a negative impact on prognosis. Treatment effects for AF or HF tend to show bidirectional benefit, whereas data is limited toward impacts on LA dysfunction. Patients with AF, HF, or LA dysfunction often have more than one of these conditions (either clinically manifest or occult), which may influence prognosis. Established treatment pathways for AF or HF tend to show benefits in the second condition, whereas there is limited data to determine effects on LA dysfunction, or whether LA dysfunction may be directly targeted for therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.